City State Bank purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 800 shares of the company’s stock, valued at approximately $55,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Cromwell Holdings LLC boosted its stake in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Studio Investment Management LLC boosted its stake in Henry Schein by 3.8% during the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after purchasing an additional 172 shares during the last quarter. Simplify Asset Management Inc. boosted its stake in Henry Schein by 5.0% during the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after purchasing an additional 175 shares during the last quarter. Central Pacific Bank Trust Division boosted its stake in Henry Schein by 2.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock worth $706,000 after purchasing an additional 200 shares during the last quarter. Finally, Huntington National Bank boosted its stake in Henry Schein by 16.8% during the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock worth $110,000 after purchasing an additional 218 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.
Henry Schein Stock Up 1.5 %
Shares of HSIC opened at $70.70 on Tuesday. The firm has a market cap of $8.81 billion, a P/E ratio of 29.09, a price-to-earnings-growth ratio of 2.30 and a beta of 0.89. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The company’s 50-day moving average price is $72.14 and its 200 day moving average price is $70.47. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on HSIC shares. Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Evercore ISI lifted their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Seven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.40.
Read Our Latest Report on Henry Schein
Insider Activity at Henry Schein
In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.14% of the stock is owned by insiders.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- 3 Small Caps With Big Return Potential
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Technology Stocks Explained: Here’s What to Know About Tech
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.